|
業務類別
|
-- |
|
業務概覽
|
Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China, Asia Pacific (excluding Mainland China), North America, South America, Oceania, and Europe. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others. |
| 公司地址
| B8 Building, No. 188 Yizhou Road, 11th Floor, Xuhui District, Shanghai, CHN, 200233 |
| 電話號碼
| +86 2133395800 |
| 傳真號碼
| +86 2134611802 |
| 公司網頁
| https://www.henlius.com |
| 員工數量
| 3515 |
| Dr. Jun Zhu |
Director and Chief Executive Officer |
-- |
15/04/2025 |
|
|
| Dr. Guoping Zhao |
Independent Director |
15/04/2025 |
| Mr. Wenjie Zhang |
Chairman of the Board |
15/04/2025 |
| Mr. Tak Young So |
Independent Director |
15/04/2025 |
| Dr. Xingli Wang |
Director |
15/04/2025 |
| Dr. Lik Yuen Chan |
Independent Director |
15/04/2025 |
| Dr. Ruilin Song |
Independent Director |
15/04/2025 |
| Ms. Xiaohui Guan |
Director |
15/04/2025 |
| Mr. Qiyu Chen |
Director |
15/04/2025 |
| Dr. Jun Zhu |
Director and Chief Executive Officer |
15/04/2025 |
| Mr. Deyong Wen |
Director |
15/04/2025 |
| Mr. Yifang Wu |
Director |
15/04/2025 |
|
|
|
|
